XML 29 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurement Of Assets And Liabilities
9 Months Ended
Sep. 30, 2022
Fair Value Measurement Of Assets And Liabilities [Abstract]  
Fair Value Measurement Of Assets And Liabilities 8. Fair value measurement of assets and liabilities

Assets and liabilities measured and recorded at fair value on a recurring basis

The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021:

Quoted Prices in

Quoted Prices in

Balances as of

active markets for

Significant other

Unobservable

Balances as of

active markets for

Significant other

Unobservable

September 30,

identical Assets

observable inputs

inputs

December 31,

identical Assets

observable inputs

inputs

Description

2022

(Level 1)

(Level 2)

(Level 3)

2021

(Level 1)

(Level 2)

(Level 3)

(In millions)

Assets

Cash and Cash Equivalents:

Money market

$                                         492 

$                                                 492 

$                                 — 

$                                 — 

$                           1,079 

$                           1,079 

$                                 — 

$                                 — 

Foreign government debt securities (1)

16 

16 

Restricted Cash and cash equivalents:

Money market

349 

349 

210 

210 

Foreign government debt securities (Central Bank of Brazil Mandatory Guarantee) (1)

296 

296 

Investments:

Foreign government debt securities (Central Bank of Brazil Mandatory Guarantee) (1)

1,013 

1,013 

602 

602 

U.S. government debt securities (1)

708 

708 

150 

150 

Foreign government debt securities (1) (2)

88 

88 

78 

78 

Corporate debt securities

15 

15 

Other Assets:

Derivative instruments

3 

3 

17 

17 

USDC

4 

4 

Customer crypto-assets safeguarding assets

15 

15 

Total Assets

$                                      2,687 

$                                              2,669 

$                                18 

$                                 — 

$                           2,448 

$                           2,431 

$                                 — 

$                                17 

Liabilities:

Salaries and social security payable:

Long-term retention plan

$                                           44 

$                                                   — 

$                                44 

$                                 — 

$                               103 

$                                 — 

$                               103 

$                                 — 

Other Liabilities:

Contingent considerations

9 

9 

9 

9 

Derivative instruments

30

30

6 

6 

Customer crypto-assets safeguarding liabilities

15 

15 

Total Liabilities

$                                           98 

$                                                   — 

$                                89 

$                                   9 

$                               118 

$                                 — 

$                               103 

$                                15 

(1)Measured at fair value with impact on the consolidated statement of income for the application of the fair value option. (See Note 2 – Fair value option applied to certain financial instruments.)

(2)As of September 30, 2022 and December 31, 2021 includes $15 million and $13 million, respectively, of investments from securitization transactions that are restricted to the payment of amounts due to third-party investors. (See Note 4 - Cash, cash equivalents, restricted cash and cash equivalents and investments.)

As of September 30, 2022 and December 31, 2021, the Company’s assets and liabilities were valued at fair value using i) Level 1 inputs: unadjusted quoted prices in active markets (Level 1 instrument valuations are obtained from observable inputs that reflect quoted prices (unadjusted) for identical assets in active markets); ii) Level 2 inputs: obtained from readily-available pricing sources for comparable instruments as well as instruments with inactive markets at the measurement date; and iii) Level 3 inputs: valuations based on unobservable inputs reflecting Company’s assumptions (fair value of derivative instruments is determined considering the prevailing risk free interest rate and spot exchange rate, fair value of contingent considerations is determined based on the probability of achievement of the performance targets arising from each acquisition, as well as the Company’s historical experience with similar arrangements).

The following tables summarize the reconciliation of the financial assets and liabilities measured at fair value using Level 3 inputs as of September 30, 2022 and December 31, 2021:

Nine Months Ended September 30, 2022

Derivative Instruments, net

Contingent Considerations

Balance, beginning of the period

$

11

$

(9)

Net Additions

3

Settlements

7

Foreign Currency Translation

(5)

Gain (Losses) in Other Comprehensive Income

(15)

Gain (Losses) on Income Statement

(28)

Transfers out of level 3

27

Balance, end of the period

$

$

(9)

Year Ended December 31, 2021

Derivative Instruments, net

Contingent Considerations

Balance, beginning of the year

$

(14)

$

(5)

Net Additions

3 

(4)

Settlements

14 

Foreign Currency Translation

(3)

Gain (Losses) in Other Comprehensive Income

11 

Gain (Losses) on Income Statement

Transfers out of level 3

Balance, end of the year

$

11

$

(9)

As of September 30, 2022, the cost and the estimated fair value of the Company’s investment in corporate debt securities classified as available for sale, all with an effective maturity of one year or less, were $15 million. Also, for the nine-month period ended September 30, 2022, proceeds from these sales amounted to $141 million and gross realized gains amounted to less than a million. The cost of these securities was determined under a specific identification basis.

Financial assets and liabilities not measured and recorded at fair value

As of September 30, 2022 and December 31, 2021, the carrying value of the Company’s financial assets (except for loans receivable) and liabilities (except for the 2026, 2028 and 2031 Notes) not measured at fair value approximated their fair value mainly because of their short-term maturity. These assets and liabilities included cash and cash equivalents, restricted cash and cash equivalents and short-term investments (excluding money markets, corporate debt securities and U.S. and foreign government debt securities), accounts receivable, credit cards receivable and other means of payment, accounts payable and accrued expenses, funds payable to customers, amounts payable due to credit and debit card transactions, salaries and social security payable (excluding variable LTRP), loans payables and other financial liabilities (except for the 2026, 2028 and 2031 Notes) and other liabilities (excluding variable LTRP, contingent considerations and derivative instruments). If these financial instruments were measured at fair value in the financial statements, cash and restricted cash would be classified as Level 1 and the remaining financial instruments would be classified as Level 2.

On the other hand, as of September 30, 2022 and December 31, 2021, the estimated fair value of the loans receivables, which is based on Level 3 inputs, is $1,848 million and $1,260 million, respectively, and were determined based on Company’s assumptions. As of September 30, 2022 and December 31, 2021, the estimated fair value of the 2026 and 2031 Notes, which is based on Level 1 inputs, is $857 million and $1,105 million, respectively. As of September 30, 2022 and December 31, 2021, the estimated fair value of the 2028 Notes, which is based on Level 2 inputs, is $299 million and $331 million, respectively, and were determined based on market interest rates. The rest of the loans payable and other financial liabilities approximate their fair value because the effective interest rates are not materially different from market interest rates.

The following table summarizes the estimated fair value for those financial assets and liabilities of the Company not measured at fair value as of September 30, 2022 and December 31, 2021:

Balances as of

Estimated fair value as of

Balances as of

Estimated fair value as of

September 30,

September 30,

December 31,

December 31,

2022

2022

2021

2021

(In millions)

Assets

Cash and cash equivalents

$                               963

$                                       963

$                    1,490

$                    1,490

Restricted cash and cash equivalents

724

724

557

557

Investments

438

438

16

16

Accounts receivable, net

108

108

98

98

Credit Card receivables and other means of payment, net

2,550

2,550

1,839

1,839

Loans receivable, net

1,766

1,848

1,260

1,260

Total Assets

$                            6,549

$                                    6,631

$                    5,260

$                    5,260

Liabilities

Accounts payable and accrued expenses

$                            1,155

$                                    1,155

$                    1,036

$                    1,036

Funds payable to customers

2,558

2,558

2,393

2,393

Amounts payable due to credit and debit card transactions

422

422

341

341

Salaries and social security payable

306

306

230

230

Loans payable and other financial liabilities (*)

4,689

4,311

3,518

3,534

Other liabilities

139

139

117

117

Total Liabilities

$                            9,269

$                                    8,891

$                    7,635

$                    7,651

(*) The fair value of the 2028 Notes (including the conversion option) is disclosed in Note 11.